Wells Fargo analyst Christopher Carey reiterated a Buy rating on Procter & Gamble (PG – Research Report) yesterday and set a price target of $185.00.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Christopher Carey has given his Buy rating due to a combination of factors that highlight Procter & Gamble’s potential for growth and resilience in the face of current market conditions. Despite short-term volatility in inventory levels, Carey notes the strength in U.S. consumption and the company’s ability to maintain its earnings per share (EPS) within the lower end of its fiscal year 2025 guidance, provided there is a rebound in inventory re-orders.
Looking forward to fiscal year 2026, Carey points out that Procter & Gamble has articulated a constructive outlook, with the potential to align with its growth algorithm. This is supported by robust global trends, excluding China and the Middle East/Africa, and strong share gains in various markets. The company’s strategic confidence and ability to navigate factors like foreign exchange rates and commodity prices further reinforce the Buy rating.
Carey covers the Consumer Defensive sector, focusing on stocks such as Mondelez International, Procter & Gamble, and Constellation Brands. According to TipRanks, Carey has an average return of 0.4% and a 46.00% success rate on recommended stocks.